Skip to main content
Log in

Genetic and Non-Genetic Determinants of Circulating Levels of Adiponectin in a Cohort of Chilean Subjects

  • Original Research Article
  • Published:
Molecular Diagnosis & Therapy Aims and scope Submit manuscript

Abstract

Background

Low adiponectin levels have been associated with obesity, diabetes, coronary disease and polymorphisms. The aim of this study was to assess the clinical and genetic factors related to adiponectin levels in a Chilean adult population.

Methods

Four groups of 27 individuals, stratified by gender and abdominal obesity, were included in this cross-sectional study. Physical activity level, cardiovascular risk factors and therapy were assessed. Anthropometric measurements, adiponectin, glucose, insulin, hs-CRP, rs1501299, rs2241766, rs266729 and rs17300539 single nucleotide polymorphisms of the adiponectin gene were determined.

Results

Adiponectin levels were inversely correlated with waist circumference, waist-to-hip ratio, weight, body mass index, insulin levels, homeostasis model insulin resistance index (HOMA-IR) and physical activity. Mean adiponectin levels were lower in men (10.1 ± 3.6 vs 11.9 ± 2.9 μg/mL, p = 0.0051), obese (9.9 ± 3.2 vs 12.1 ± 3.3, p < 0.01), physically inactive (8.9 ± 3.2 vs 11.0 ± 2.8, p = 0.015) and insulin-resistant individuals (10.2 ± 3.1 vs 12.9 ± 3.9; p = 0.005). Adiponectin levels were lower in subjects with GG genotype (rs1501299) compared with those with TT or GT variants (6.9 ± 4.6 vs 12.2 ± 2.9 and 11.5 ± 3.4 μg/mL, p = 0.006) but were similar in the other polymorphisms studied.

Conclusion

Lower adiponectin levels were related to gender, abdominal obesity, physical activity and insulin resistance and were less influenced by the polymorphisms studied.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. York DA, Rossner S, Caterson I, Chen CM, James WP, Kumanyika S, et al. Prevention conference VII: obesity, a worldwide epidemic related to heart disease and stroke: Group I: worldwide demographics of obesity. Circulation. 2004;110(18):e463–70.

    Article  PubMed  Google Scholar 

  2. Greenberg AS, Obin MS. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr. 2006;83(2):461S–5S.

    CAS  PubMed  Google Scholar 

  3. Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M, et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J. 2004;68(11):975–81.

    Article  CAS  PubMed  Google Scholar 

  4. Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M, Boeing H, et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet. 2003;361(9353):226–8.

    Article  CAS  PubMed  Google Scholar 

  5. Sattar N, Wannamethee G, Sarwar N, Tchernova J, Cherry L, Wallace AM, et al. Adiponectin and coronary heart disease: a prospective study and meta-analysis. Circulation. 2006;114(7):623–9.

    Article  CAS  PubMed  Google Scholar 

  6. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257(1):79–83.

    Article  CAS  PubMed  Google Scholar 

  7. Yu Z, Ye X, Wang J, Qi Q, Franco OH, Rennie KL, et al. Associations of physical activity with inflammatory factors, dipocytokines, and metabolic syndrome in middle-aged and older chinese people. Circulation. 2009;119(23):2969–77.

    Article  CAS  PubMed  Google Scholar 

  8. Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Hussain T, Yakout S, et al. Adiponectin gene polymorphisms (T45G and G276T), adiponectin levels and risk for metabolic diseases in an Arab population. Gene. 2012;493(1):142–7.

    Article  CAS  PubMed  Google Scholar 

  9. Oliveira CS, Saddi-Rosa P, Crispim F, Canani LH, Gerchman F, Giuffrida FM, et al. Association of ADIPOQ variants, total and high molecular weight adiponectin levels with coronary artery disease in diabetic and non-diabetic Brazilian subjects. J Diabetes Complicat. 2012;26(2):94–8.

  10. Jang Y, Chae JS, Koh SJ, Hyun YJ, Kim JY, Jeong YJ, et al. The influence of the adiponectin gene on adiponectin concentrations and parameters of metabolic syndrome in non-diabetic Korean women. Clin Chim Acta. 2008;391(1–2):85–90.

    Article  CAS  PubMed  Google Scholar 

  11. Menzaghi C, Trischitta V, Doria A. Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes. 2007;56(5):1198–209.

    Article  CAS  PubMed  Google Scholar 

  12. Suriyaprom K, Phonrat B, Tungtrongchitr R. Association of adiponectin gene −11377C>G polymorphism with adiponectin levels and the metabolic syndrome in Thais. Asia Pac J Clin Nutr. 2014;23(1):167–73.

    CAS  PubMed  Google Scholar 

  13. Mousavinasab F, Tahtinen T, Jokelainen J, Koskela P, Vanhala M, Oikarinen J, et al. Common polymorphisms (single-nucleotide polymorphisms SNP+45 and SNP+276) of the adiponectin gene regulate serum adiponectin concentrations and blood pressure in young Finnish men. Mol Genetics Metab. 2006;87(2):147–51.

    Article  CAS  Google Scholar 

  14. Siitonen N, Pulkkinen L, Lindstrom J, Kolehmainen M, Eriksson JG, Venojarvi M, et al. Association of ADIPOQ gene variants with body weight, type 2 diabetes and serum adiponectin concentrations: the Finnish Diabetes Prevention Study. BMC Med Genetics. 2011;12:5.

    Article  CAS  Google Scholar 

  15. Patel S, Flyvbjerg A, Kozakova M, Frystyk J, Ibrahim IM, Petrie JR, et al. Variation in the ADIPOQ gene promoter is associated with carotid intima media thickness independent of plasma adiponectin levels in healthy subjects. Eur Heart J. 2008;29(3):386–93.

    Article  CAS  PubMed  Google Scholar 

  16. Hivert MF, Manning AK, McAteer JB, Florez JC, Dupuis J, Fox CS, et al. Common variants in the adiponectin gene (ADIPOQ) associated with plasma adiponectin levels, type 2 diabetes, and diabetes-related quantitative traits: the Framingham Offspring Study. Diabetes. 2008;57(12):3353–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Warodomwichit D, Shen J, Arnett DK, Tsai MY, Kabagambe EK, Peacock JM, et al. ADIPOQ polymorphisms, monounsaturated fatty acids, and obesity risk: the GOLDN study. Obesity. 2009;17(3):510–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Rizk NM, El-Menyar A, Marei I, Sameer M, Musad T, Younis D, et al. Association of adiponectin gene polymorphism (+T45G) with acute coronary syndrome and circulating adiponectin levels. Angiology. 2013;64(4):257–65.

    Article  CAS  PubMed  Google Scholar 

  19. Woo JG, Dolan LM, Deka R, Kaushal RD, Shen Y, Pal P, et al. Interactions between noncontiguous haplotypes in the adiponectin gene ACDC are associated with plasma adiponectin. Diabetes. 2006;55(2):523–9.

    Article  CAS  PubMed  Google Scholar 

  20. Teo K, Chow CK, Vaz M, Rangarajan S, Yusuf S, Group PI-W. The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. Am Heart J. 2009;158(1):1–7 e1.

  21. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–95.

    Article  PubMed  Google Scholar 

  22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.

    Article  CAS  PubMed  Google Scholar 

  23. World Health Organization. Global strategy for the prevention and control of noncommunicable diseases. Geneva: World Health Organization; 2000.

  24. Garmendia ML, Lera L, Sánchez H, Uauy R, Albala C. Valores normativos de resistencia a la insulina mediante HOMA-IR en adultos mayores de Santiago de Chile. Rev Méd Chil. 2009;137:1409–16.

    PubMed  Google Scholar 

  25. Enns JE, Taylor CG, Zahradka P. Variations in adipokine genes AdipoQ, Lep, and LepR are associated with risk for obesity-related metabolic disease: the modulatory role of gene-nutrient interactions. J Obes. 2011;2011:168659.

    Article  PubMed Central  PubMed  Google Scholar 

  26. Laumen H, Saningong AD, Heid IM, Hess J, Herder C, Claussnitzer M, et al. Functional characterization of promoter variants of the adiponectin gene complemented by epidemiological data. Diabetes. 2009;58(4):984–91.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Salazar LA, Melo C, Cavalli S, Hinuy H, Hirata M, Hirata R. Micrométodo para extraçäo de DNA genômico útil no diagnóstico molecular da Hipercolesterolemia Familial. Rev Bras Anál Clín. 2001;33(3):8.

    Google Scholar 

  28. Namvaran F, Azarpira N, Geramizadeh B, Rahimi-Moghaddam P. Distribution and genotype frequency of adiponectin (+45 T/G) and adiponectin receptor2 (+795 G/A) single nucleotide polymorphisms in Iranian population. Gene. 2011;486(1–2):97–103.

  29. Rasmussen-Torvik LJ, Pankow JS, Jacobs DR Jr, Steinberger J, Moran AM, Sinaiko AR. Influence of waist on adiponectin and insulin sensitivity in adolescence. Obesity. 2009;17(1):156–61.

    Article  PubMed Central  PubMed  Google Scholar 

  30. Rabe K, Lehrke M, Parhofer KG, Broedl UC. Adipokines and insulin resistance. Mol Med. 2008;14(11–12):741–51.

  31. Duncan BB, Schmidt MI, Pankow JS, Bang H, Couper D, Ballantyne CM, et al. Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes. 2004;53(9):2473–8.

    Article  CAS  PubMed  Google Scholar 

  32. Laughlin GA, Barrett-Connor E, May S. Sex-specific determinants of serum adiponectin in older adults: the role of endogenous sex hormones. Int J Obes. 2007;31(3):457–65.

    Article  CAS  Google Scholar 

  33. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005;366(9497):1640–9.

    Article  PubMed  Google Scholar 

  34. Frederiksen L, Nielsen TL, Wraae K, Hagen C, Frystyk J, Flyvbjerg A, et al. Subcutaneous rather than visceral adipose tissue is associated with adiponectin levels and insulin resistance in young men. J Clin Endocrinol Metab. 2009;94(10):4010–5.

    Article  CAS  PubMed  Google Scholar 

  35. Kim DH, Kim C, Ding EL, Townsend MK, Lipsitz LA. Adiponectin levels and the risk of hypertension: a systematic review and meta-analysis. Hypertension. 2013;62(1):27–32.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  36. Bluher M, Bullen JW Jr, Lee JH, Kralisch S, Fasshauer M, Kloting N, et al. Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training. J Clin Endocrinol Metab. 2006;91(6):2310–6.

    Article  PubMed  Google Scholar 

  37. Simpson KA, Singh MA. Effects of exercise on adiponectin: a systematic review. Obesity. 2008;16(2):241–56.

    Article  CAS  PubMed  Google Scholar 

  38. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation. 1999;100(25):2473–6.

  39. Ramya K, Ayyappa KA, Ghosh S, Mohan V, Radha V. Genetic association of ADIPOQ gene variants with type 2 diabetes, obesity and serum adiponectin levels in south Indian population. Gene. 2013;532(2):253–62.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by Dirección de Investigación y Desarrollo, Universidad de La Frontera (DIDUFRO DI13-0012). J. R. is the recipient of fellowship from CONICYT, Chile. N. S. is the recipient of a post-doctoral fellowship from Convenio de Desempeño—Universidad de La Frontera.

Author contributions

FL, PS and LAS conceived and designed the experiment; NS, JR and LAS performed the experiments; FL, PS, NS and LAS analysed the data; LAS and FL contributed reagents/materials/analysis tools; FL and LAS wrote the paper.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Fernando Lanas or Luis Salazar.

Ethics declarations

Disclosure statement

None of the authors has a relationship with a for-profit company or institution. No competing financial interests exist.

Conflict of interest

The authors have no conflict of interest relevant to the content of this article.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lanas, F., Serón, P., Saavedra, N. et al. Genetic and Non-Genetic Determinants of Circulating Levels of Adiponectin in a Cohort of Chilean Subjects. Mol Diagn Ther 19, 197–204 (2015). https://doi.org/10.1007/s40291-015-0146-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40291-015-0146-3

Keywords

Navigation